v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Repurchase Agreements
The following table presents the Company’s 2024 Repurchase Program activity:
Total number of shares purchasedAverage price paid per shareApproximate value of shares purchased
Year Ended December 31, 20242,545,402 $11.79 $30,000 
Year Ended December 31, 20251,856,907 $16.15 $29,997 
The following table presents the Company’s 2025 Repurchase Program activity for the periods indicated:
Total number of shares purchasedAverage price paid per shareApproximate value of shares purchased
Year Ended December 31, 2025431,217 $25.94 $11,188 
Six Months Ended June 30, 2026
3,766,336 $24.18 $91,069 
The following table presents the Company’s 2026 Repurchase Program activity:
Total number of shares purchasedAverage price paid per shareApproximate value of shares purchased
Six Months Ended June 30, 2026
2,008,243 $25.85 $51,908 
Schedule of RSU Activity
The following table summarizes the Company’s RSU activity under the New Plan since December 31, 2025:
Number of RSUsWeighted-
average grant
date fair value
($)
Outstanding, December 31, 20251,947,584 12.90 
Granted1,374,700 23.91 
Vested and settled(796,552)11.33 
Cancelled, expired(254,154)16.77 
Outstanding, June 30, 20262,271,578 19.68 
Schedule of PSU Activity
The following table summarizes the Company’s PSU activity under the New Plan since December 31, 2025:
Number of RSUsWeighted-
average grant
date fair value
($)
Outstanding, December 31, 2025— — 
Granted317,000 34.45 
Outstanding, June 30, 2026317,000 34.45 
Schedule of Stock Options Granted
The following table summarizes the Company’s stock options granted in Canadian dollars under the Original Plan and the New Plan:
Number
of Options		Weighted-
Average
Exercise Price
($)		Weighted-
Average
Contractual
Term
(years)		Aggregate
intrinsic value
($)
Outstanding, December 31, 2025572,112 18.17 4.316,081 
Granted— — 
Exercised(115,357)9.56 
Cancelled, expired(7,546)29.50 
Outstanding, June 30, 2026449,209 19.47 3.914,182 
The following table summarizes the Company’s stock options granted in U.S. dollars under the New Plan and the Inducement Plan:
Number
of Options		Weighted-
Average
Exercise Price
($)		Weighted-
Average
Contractual
Term
(years)		Aggregate
intrinsic value
($)
Outstanding, December 31, 20257,816,277 12.71 7.47109,157 
Granted2,005,750 23.83 
Exercised(1,003,662)10.46 
Cancelled, expired(892,327)14.77 
Outstanding, June 30, 20267,926,038 15.58 7.8286,336 
Schedule of Stock-Based Compensation Expense for Equity Classified Instruments Stock-based compensation expense for equity classified instruments, RSUs, PSUs as well as the financial statement impact of the amortization and periodic revaluation of liability classified instruments, are recorded in research and development expense and general and administration expense as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Research and development expense
$3,313 $2,891 $7,106 $6,052 
General and administrative expense
7,887 2,832 10,917 5,945 
Schedule of Estimated Fair Value of Stock Options Assumptions
The estimated fair value of stock options granted under the New Plan was determined using the Black-Scholes option pricing model with the following weighted-average assumptions:
Six Months Ended June 30,
20262025
Dividend yield0 %0 %
Expected volatility62.9 %63.1 %
Risk-free interest rate3.90 %4.49 %
Expected average life of options6.03 years6.06 years
The weighted-average Black-Scholes option pricing assumptions for liability classified stock options outstanding at June 30, 2026 and 2025 are as follows:
Six Months Ended June 30,
20262025
Dividend yield
0 %0 %
Expected volatility
45.1 %46.9 %
Risk-free interest rate
2.72 %2.60 %
Expected average option term
0.60 years0.56 years
Number of liability classified stock options outstanding
49,402272,330